Brought to you by 
SmithKline licenses NaviCyte software for use with compounds
13 Jul 1999
Executive Summary
NaviCyte has granted SmithKline a non-exclusive license to its software and computational models for use with SKB's compound libraries. NaviCyte gets development support of its In Vitro Determination for Evaluation of Absorption software in return.
Deal Industry
- Biotechnology
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
Deal Status
- Final
Deal Type
-
Alliance
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
SmithKline licenses NaviCyte software for use with compounds
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice